½ÃÀ庸°í¼­
»óǰÄÚµå
1534234

¼¼°èÀÇ Ã·´Ü â»ó ÇǺ¹Àç ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Advanced Wound Dressings Market Size Study, by Product Type, by Indication, by End-User and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 74¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù.

2024³â 78¾ï 3,000¸¸ ´Þ·¯¿¡¼­ 2032³â 121¾ï 1,000¸¸ ´Þ·¯·Î ¼ºÀåÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È 5.5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÷´Ü â»ó ÇǺ¹Àç´Â ¸¸¼º »óó, ±Þ¼º »óó, ¼ö¼ú »óó µî ´Ù¾çÇÑ À¯ÇüÀÇ »óóÀÇ Ä¡À¯¸¦ º¸´Ù ºü¸£°í È¿°úÀûÀ¸·Î ÃËÁøÇϵµ·Ï ¼³°èµÈ Ư¼ö ÀÇ·á Á¦Ç°ÀÔ´Ï´Ù. °ÅÁ ºØ´ë¿Í °°Àº ±âÁ¸ â»ó ÇǺ¹Àç¿Í ´Þ¸®, ÷´Ü â»ó ÇǺ¹Àç´Â »óó Ä¡À¯¸¦ À§ÇÑ ÃÖÀûÀÇ È¯°æÀ» Á¦°øÇÏ´Â Çõ½ÅÀûÀÎ ¼ÒÀç¿Í ±â¼úÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù. »ïÃâ¹° °ü¸®, ½Àµµ ±ÕÇü À¯Áö, °¨¿° ¿¹¹æ, Á¶Á÷ Àç»ýÀ» ÃËÁøÇÏ¿© ȯÀÚ ¿¹Èĸ¦ °³¼±Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

´ç´¢º´¼º Á·ºÎ±Ë¾ç, ¿åâ, Á¤¸Æ¼º ÇÏÁö±Ë¾ç°ú °°Àº ¸¸¼º »óóÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÏ¹Ý Àα¸¿¡¼­ ¸¸¼º »óó Ä¡·á¸¦ ¹Þ´Â ȯÀÚ ¼ö´Â ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¸¸¼º »óó Ä¡·á¸¦ ¹Þ´Â ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î Çõ½ÅÀûÀÎ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÐƼ¾î(Frontier)°¡ 2021³â ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, Á¤¸Æ¼º ÇÏÁö ±Ë¾ç(VLU)ÀÇ Àü ¼¼°è À¯º´·üÀº ¾à 2.0%·Î Ãß»êµË´Ï´Ù. µû¶ó¼­ Á¤¸Æ¼º ÇÏÁö ±Ë¾çÀÇ À¯º´·ü Áõ°¡´Â Ä¡·á ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ Ã¢»ó °ü¸® Á¦Ç°ÀÇ Ã¤ÅÃÀ» È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÷´Ü â»ó °ü¸® Á¦Ç°À¸·ÎÀÇ ¿ì¼±Àû Àüȯ, Á¦Ç° Ãâ½Ã ¹× ±â¼ú Çõ½ÅÀÇ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ ½ÅÈï ½ÃÀå ÁøÃâÀº ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ³ôÀº Ä¡·á ºñ¿ë°ú ±ä ȸº¹ ±â°£Àº ½ÃÀå¿¡¼­ ÷´Ü â»ó Ä¡·á Á¦Ç°ÀÇ Ã¤ÅÃÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀÌ Æ÷ÇԵ˴ϴÙ. ºÏ¹Ì´Â ¼¼°è ÷´Ü â»ó ÇǺ¹Àç ½ÃÀå¿¡¼­ ¼öÀÍ Ãø¸é¿¡¼­ Áö¹èÀûÀÎ Áö¿ªÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀº ¸¸¼º »óóÀÇ À¯º´·ü Áõ°¡¿Í °í±Þ µå·¹½Ì Á¦Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀåÀº ¸¸¼º »óó À¯º´·ü Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ¿¡ µû¶ó ÁÖ¿ä ±â¾÷µéÀÌ ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ Áö¸®Àû ÀÔÁö¸¦ È®´ëÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ÁÖ¿ä ¿ä¾à

  • ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦2Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå Á¤ÀÇ¿Í Á¶»ç °¡Á¤

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç °¡Á¤
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ»çÇ×
    • °ø±ÞÃø ºÐ¼®
      • ÀÔ¼ö °¡´É¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ °üÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º â»ó°ú ±Þ¼º â»ó Áõ°¡
    • â»ó ÇǺ¹ÀçÀÇ ±â¼úÀû Áøº¸
    • ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ È®´ë
  • ½ÃÀå °úÁ¦
    • °í¾×ÀÇ Ä¡·áºñ
    • ȸº¹ ±â°£ÀÇ Àå±âÈ­
    • ½ÅÈï ±¹°¡ÀÇ »óȯ Á¤Ã¥ °á¿©
  • ½ÃÀå ±âȸ
    • ÷´Ü â»ó °ü¸® Á¦Ç°À¸·ÎÀÇ ¿ì¼± À̵¿
    • Á¦Ç° Ãâ½Ã¿Í ±â¼ú Çõ½Å Áõ°¡
    • ½ÅÈï ½ÃÀå¿¡ ´ëÇÑ ÁÖ¿ä ±â¾÷ ÁøÃâ

Á¦4Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨·ÎÀÇ ¹Ì·¡ÁöÇâÀû Á¢±Ù¹ý
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç° À¯Çüº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • ¾ËÁö³×ÀÌÆ® µå·¹½Ì
    • ÇÏÀ̵å·Î°Ö µå·¹½Ì
    • Çʸ§ µå·¹½Ì
    • ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì
    • Ç×±Õ µå·¹½Ì
    • Æû µå·¹½Ì
    • ±âŸ

Á¦6Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÀûÀÀÁõº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • ´ç´¢º´¼º Á·ºÎ±Ë¾ç
    • ¿åâ
    • ¼ö¼úâ
    • ±âŸ

Á¦7Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • º´¿ø
    • Áø·á¼Ò
    • ÀçÅÃÀÇ·á
    • ±âŸ

Á¦8Àå ÷´Ü â»ó ÇǺ¹Àç ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ºÏ¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Smith & Nephew(U.K.)
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • 3 M(U.S.)
    • Coloplast A/S(Denmark)
    • ConvaTec Inc.(U.K.)
    • Plastod S.p.A.(Italy)
    • Integra LifeSciences Corporation(U.S.)
    • Molnlycke Health Care AB(Sweden)
    • Medline Industries, LP(U.S.)
    • Covalon Technologies Ltd.(Canada)
    • Medtronic Plc(Ireland)
    • Johnson & Johnson(U.S.)
    • Hartmann Group(Germany)
    • KCI Licensing, Inc.(U.S.)
    • BSN Medical(Germany)
    • Derma Sciences, Inc.(U.S.)

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
ksm 24.09.11

Global Advanced Wound Dressings Market size was valued at USD 7.45 billion in 2023. The market is projected to grow from USD 7.83 billion in 2024 to USD 12.11 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period. Advanced wound dressings are specialized medical products designed to promote faster and more effective healing of various types of wounds, including chronic, acute, and surgical wounds. Unlike traditional wound dressings, such as gauze or bandages, advanced wound dressings incorporate innovative materials and technologies that provide an optimal environment for wound healing. They are engineered to manage exudate, maintain moisture balance, prevent infection, and facilitate tissue regeneration, thereby improving patient outcomes.

There is an increase in the prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, this is further expected to drive the number of patients undergoing treatment for chronic wounds among the general population. Furthermore, the increasing patient population for the treatment of chronic wounds is resulting in the growing demand for innovative products among patients globally. In addition, according to the data published by Frontiers in 2021, it was estimated that the global prevalence of venous leg ulcers (VLU) was around 2.0%. Hence, the increasing prevalence of venous leg ulcers is expected to boost the demand for treatment, resulting in the growing adoption of wound care products. Moreover, the preferential shift to advanced wound management products, increasing product launches and innovation, and expansion of key players into emerging markets present various lucrative opportunities over the forecast years. However, the high treatment cost and longer duration of the recovery period are hampering the adoption of advanced wound care products in the market.

The key regions considered for the Global Advanced Wound Dressings Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Advanced Wound Dressings Market in terms of revenue. The market growth in the region is being attributed to factors including the growing prevalence of chronic wounds and rising awareness of advanced dressing products. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by the increasing prevalence of chronic wounds, resulting in a rising number of key players focusing on expanding their geographical presence to strengthen their global presence in the market.

Major market players included in this report are:

  • Smith & Nephew (U.K.)
  • 3M (U.S.)
  • Coloplast A/S (Denmark)
  • ConvaTec Inc. (U.K.)
  • Plastod S.p.A. (Italy)
  • Integra LifeSciences Corporation (U.S.)
  • Molnlycke Health Care AB (Sweden)
  • Medline Industries, LP (U.S.)
  • Covalon Technologies Ltd. (Canada)
  • Medtronic Plc (Ireland)
  • Johnson & Johnson (U.S.)
  • Hartmann Group (Germany)
  • KCI Licensing, Inc. (U.S.)
  • BSN Medical (Germany)
  • Derma Sciences, Inc. (U.S.)

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Alginate Dressings
  • Hydrogel Dressings
  • Film Dressings
  • Hydrocolloid Dressings
  • Antimicrobial Dressings
  • Foam Dressings
  • Others

By Indication:

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Surgical Wounds
  • Others

By End-User:

  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Advanced Wound Dressings Market Executive Summary

  • 1.1. Global Advanced Wound Dressings Market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Indication
    • 1.3.3. By End-User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Advanced Wound Dressings Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Advanced Wound Dressings Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Cases of Chronic and Acute Wounds
    • 3.1.2. Technological Advancements in Wound Dressings
    • 3.1.3. Growing Investments in R&D Initiatives
  • 3.2. Market Challenges
    • 3.2.1. High Cost of Treatment
    • 3.2.2. Longer Duration of Recovery Period
    • 3.2.3. Lack of Reimbursement Policies in Developing Countries
  • 3.3. Market Opportunities
    • 3.3.1. Preferential Shift to Advanced Wound Management Products
    • 3.3.2. Increasing Product Launches and Innovation
    • 3.3.3. Expansion of Key Players into Emerging Markets

Chapter 4. Global Advanced Wound Dressings Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Advanced Wound Dressings Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Advanced Wound Dressings Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Alginate Dressings
    • 5.2.2. Hydrogel Dressings
    • 5.2.3. Film Dressings
    • 5.2.4. Hydrocolloid Dressings
    • 5.2.5. Antimicrobial Dressings
    • 5.2.6. Foam Dressings
    • 5.2.7. Others

Chapter 6. Global Advanced Wound Dressings Market Size & Forecasts by Indication 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Advanced Wound Dressings Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Diabetic Foot Ulcers
    • 6.2.2. Pressure Ulcers
    • 6.2.3. Surgical Wounds
    • 6.2.4. Others

Chapter 7. Global Advanced Wound Dressings Market Size & Forecasts by End-User 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Advanced Wound Dressings Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Hospitals
    • 7.2.2. Clinics
    • 7.2.3. Homecare Settings
    • 7.2.4. Others

Chapter 8. Global Advanced Wound Dressings Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Advanced Wound Dressings Market
    • 8.1.1. U.S. Advanced Wound Dressings Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Indication breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End-User breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Advanced Wound Dressings Market
    • 8.1.3. Mexico Advanced Wound Dressings Market
  • 8.2. Europe Advanced Wound Dressings Market
    • 8.2.1. UK Advanced Wound Dressings Market
    • 8.2.2. Germany Advanced Wound Dressings Market
    • 8.2.3. France Advanced Wound Dressings Market
    • 8.2.4. Spain Advanced Wound Dressings Market
    • 8.2.5. Italy Advanced Wound Dressings Market
    • 8.2.6. Rest of Europe Advanced Wound Dressings Market
  • 8.3. Asia-Pacific Advanced Wound Dressings Market
    • 8.3.1. China Advanced Wound Dressings Market
    • 8.3.2. India Advanced Wound Dressings Market
    • 8.3.3. Japan Advanced Wound Dressings Market
    • 8.3.4. Australia Advanced Wound Dressings Market
    • 8.3.5. South Korea Advanced Wound Dressings Market
    • 8.3.6. Rest of Asia Pacific Advanced Wound Dressings Market
  • 8.4. Latin America Advanced Wound Dressings Market
    • 8.4.1. Brazil Advanced Wound Dressings Market
    • 8.4.2. Argentina Advanced Wound Dressings Market
    • 8.4.3. Colombia Advanced Wound Dressings Market
    • 8.4.4. Rest of Latin America Advanced Wound Dressings Market
  • 8.5. Middle East & Africa Advanced Wound Dressings Market
    • 8.5.1. GCC Advanced Wound Dressings Market
    • 8.5.2. South Africa Advanced Wound Dressings Market
    • 8.5.3. North Africa Advanced Wound Dressings Market
    • 8.5.4. Rest of Middle East & Africa Advanced Wound Dressings Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Smith & Nephew (U.K.)
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. 3M (U.S.)
    • 9.3.3. Coloplast A/S (Denmark)
    • 9.3.4. ConvaTec Inc. (U.K.)
    • 9.3.5. Plastod S.p.A. (Italy)
    • 9.3.6. Integra LifeSciences Corporation (U.S.)
    • 9.3.7. Molnlycke Health Care AB (Sweden)
    • 9.3.8. Medline Industries, LP (U.S.)
    • 9.3.9. Covalon Technologies Ltd. (Canada)
    • 9.3.10. Medtronic Plc (Ireland)
    • 9.3.11. Johnson & Johnson (U.S.)
    • 9.3.12. Hartmann Group (Germany)
    • 9.3.13. KCI Licensing, Inc. (U.S.)
    • 9.3.14. BSN Medical (Germany)
    • 9.3.15. Derma Sciences, Inc. (U.S.)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦